FLT3 and acute myeloid leukemia: In addition, gRNAs against FLT3 and NRAS showed specific depletion in cell lines carrying activating mutations in these genes, whereas NPM1 was depleted in four of the five AML lines including OCI-AML3 (Figure 3E).